{"id":61751,"name":"HANSA BIOPHARMA","slug":"hansa-biopharma","state":null,"country":"Sweden","description":"Biopharmaceutical company","totalSpending":360000,"filings":7,"yearlySpending":[{"year":2024,"income":120000},{"year":2025,"income":240000}],"issues":["HCR","BUD"],"firms":["TARPLIN, DOWNS & YOUNG, LLC"],"lobbyists":["ELIZABETH MURRAY","CHARLOTTE IVANCIC","EMILY MURRY","KIMBERLY BRANDT","RAISSA DOWNS","LAURA FRIEDEL","MARGARET JOSEPH","JENNIFER YOUNG","PARICK CARROLL","PAMELA SMITH","PETER FISE"],"govEntities":["Health & Human Services, Dept of (HHS)","HOUSE OF REPRESENTATIVES","SENATE","Veterans Affairs, Dept of (VA)"],"sampleDescriptions":["Kidney issues, rare disease issues","Kidney issues, access to innovation, rare disease issues","Kidney issues, access to innovation, rare disease issues","Kidney issues, access to innovation, rare disease issues","Federal budget issues"],"years":[2024,2025]}